Screening Strategies Among High-risk Populations for Anal Cancer
NCT06628570
This study is recruiting at 4 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Neoplasms
- HPV-Related Anal Squamous Cell Carcinoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 30 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Lisa Flowers
- Last updated on ClinicalTrials.gov
- August 26, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center · Miami, FL
- University of Miami School of Medicine at Jackson Memorial Hospital (JMH) · Miami, FL
Georgia · 2
- Grady Memorial Hospital · Atlanta, GA
- The Ponce Center · Atlanta, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.